An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Cannabinoid hyperemesis syndrome (CHS) is a rare clinical syndrome characterised by nausea, cyclic vomiting and severe abdominal pain in association with chronic cannabis use. It is often under-recognised or misdiagnosed, resulting in the unnecessary workup and frequent hospitalisations. Long-term treatment of CHS is abstinence from cannabis, but acute symptomatic management has been a struggle for many clinicians. The present report highlights the use of haloperidol as an agent that successfully and safely treats the unrelenting symptoms of CHS.
Bajgoric S, Samra K, Chandrapalan S et al. . Cannabinoid hyperemesis syndrome: a guide for the practicing clinician. BMJ Case Rep 2015;2015:pii: bcr2015210246 10.1136/bcr-2015-210246
-
DOI
-
PMC
-
PubMed
Degenhardt L, Chiu WT, Sampson N et al. . Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008;5:e141 10.1371/journal.pmed.0050141
-
DOI
-
PMC
-
PubMed
Patterson DA, Smith E, Monahan M et al. . Cannabinoid hyperemesis and compulsive bathing: a case series and paradoxical pathophysiological explanation. J Am Board Fam Med 2010;23:790–3. 10.3122/jabfm.2010.06.100117
-
DOI
-
PubMed
Hopkins CY, Gilchrist BL. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. J Emerg Med 2013;45:544–6. 10.1016/j.jemermed.2012.11.034
-
DOI
-
PubMed
Lu ML, Agito MD. Cannabinoid hyperemesis syndrome: marijuana is both antiemetic and proemetic. Cleve Clin J Med 2015;82:429–34. 10.3949/ccjm.82a.14023
-
DOI
-
PubMed